METHODS FOR INHIBITING BONE LOSS WITH 3,4-DIARYLCHROMAN

摘要

Methods and pharmaceutical compositions for reducing bone loss are disclosed. 3,4-diarylchromans and their pharmaceutically acceptable salts are formulated into medicaments for the treatment of bone loss due to osteoporosis or other conditions. An exemplary 3,4diarylchroman is centchroman (3,4-trans-2,2-dimethyl-3phenyl-4-(p-(beta-pyrrolid inoethoxy) phenyl!-7-methoxy-chroman). Formulations include tablets and other forms suitable for administration and controlled-release subdermal implants.